Myelosuppression

Definition: A condition in which bone marrow activity is decreased, resulting in fewer red blood cells, white blood cells, and platelets. Myelosuppression is a side effect of some cancer treatments. When myelosuppression is severe, it is called myeloablation.

Synonyms (terms occurring on more labels are shown first): myelosuppression

More information: PubMed search and possibly Wikipedia or Medpedia

Proteins predicted to cause Myelosuppression: TOP2B, TOP2B (inhibition), TOP2A (5 predictions in total)

Drugs with this side effect colchicine: postmarketing fludarabine: postmarketing gemcitabine: postmarketing linezolid: postmarketing cladribine doxorubicin hydrochloride altretamine amsacrine azathioprine busulfan carmustine cisplatin cyclophosphamide daunorubicin docetaxel etoposide fluorouracil glyburide hydroxyurea idarubicin ifosfamide lomustine alkeran mitoxantrone paclitaxel streptozocin tamoxifen citrate temozolomide teniposide Thiotepa topotecan vinorelbine mitomycin decitabine zinecard carboplatin bendamustine bleomycin sulfate lenalidomide mercaptopurine thioguanine sprycel dacarbazine ixabepilone

Drugs with this indication doxorubicin hydrochloride